ERNAW
MaterialsErnexa Therapeutics Inc Warrants
$0.06+0.02 (+63.87%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ERNAW Today?
No stock-specific AI insight has been generated for ERNAW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.02$0.12
$0.06
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE-6.9%
Profit Margin—
Debt / Equity—
Trading
Volume136K
Avg Volume (10D)—
Shares Outstanding—
ERNAW News
5 articles- Ernexa Therapeutics (ERNA) Preclinical Data Shows 100% Survival and Complete Tumor Clearance in Ovarian Cancer ModelsAdvfn·May 6, 2026
- Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer ModelsYahoo Finance·May 6, 2026
- Ernexa Therapeutics Announces 1-for-25 Reverse Stock SplitYahoo Finance·Apr 30, 2026
- Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026Yahoo Finance·Mar 31, 2026
- Ernexa Therapeutics to Participate in Virtual Investor Closing Bell SeriesYahoo Finance·Feb 20, 2026
All 5 articles loaded
Price Data
Open$0.06
Previous Close$0.04
Day High$0.09
Day Low$0.04
52 Week High$0.12
52 Week Low$0.02
52-Week Range
$0.02$0.12
$0.06
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE-6.9%
Profit Margin—
Debt / Equity—
Trading
Volume136K
Avg Volume (10D)—
Shares Outstanding—
About Ernexa Therapeutics Inc Warrants
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company is headquartered in Cambridge, Massachusetts.
MaterialsPHARMACEUTICAL PREPARATIONS
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICPHARMACEUTICAL PREPARATIONS
CIK—
Composite FIGI—
Share Class FIGI—